Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women

Clinical Endocrinology

Volumn 72, Issue 4, 2010, Pages 469-474

  Ünlütürk, Uǧur ^a   Harmanci, Ayla ^a   Yildiz, Bülent Okan ^a   Bayraktar, Miyase ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY FAT; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; BODY MASS INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; THINNESS;

EID: 77749283131     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03674.x     Document Type: Article

References (30)

1. Kershaw, E.E. Flier, J.S. (2004) Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism, 89, 2548 2556.
2. Lindsay, R.S., Funahashi, T., Hanson, R.L. et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 360, 57 58.
3. Yang, W.S., Lee, W.J., Funahashi, T. et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Journal of Clinical Endocrinology and Metabolism, 86, 3815 3819.
4. Cnop, M., Havel, P.J., Utzschneider, K.M. et al. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 46, 459 469.
5. Yatagai, T., Nagasaka, S., Taniguchi, A. et al. (2003) Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism, 52, 1274 1278.
6. Pajvani, U.B., Du, X., Combs, T.P. et al. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin Implications fpr metabolic regulation and bioactivity. Journal of Biological Chemistry, 278, 9073 9085.
7. Waki, H., Yamauchi, T., Kamon, J. et al. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes Molecular structure and multimer formation of adiponectin. Journal of Biological Chemistry, 278, 40352 40363.
8. Kobayashi, H., Ouchi, N., Kihara, S. et al. (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research, 94, e27 e31.
9. Hara, K., Horikoshi, M., Yamauchi, T. et al. (2006) Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 29, 1357 1362.
10. Lara-Castro, C., Luo, N., Wallace, P. et al. (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes, 55, 249 259.
11. Pajvani, U.B., Hawkins, M., Combs, T.P. et al. (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry, 279, 12152 12162.
12. Samal, B., Sun, Y., Stearns, G. et al. (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology, 14, 1431 1437.
13. Hammarstedt, A., Pihlajamaki, J., Rotter Sopasakis, V. et al. (2006) Visfatin is an adipokine, but it is not regulated by thiazolidinediones. Journal of Clinical Endocrinology and Metabolism, 91, 1181 1184.
14. Varma, V., Yao-Borengasser, A., Rasouli, N. et al. (2007) Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. Journal of Clinical Endocrinology and Metabolism, 92, 666 672.
15. Revollo, J.R., Korner, A., Mills, K.F. et al. (2007) Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metabolism, 6, 363 375.
16. Pagano, C., Pilon, C., Olivieri, M. et al. (2006) Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. Journal of Clinical Endocrinology and Metabolism, 91, 3165 3170.
17. Chen, M.P., Chung, F.M., Chang, D.M. et al. (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 91, 295 299.
18. Haider, D.G., Schindler, K., Schaller, G. et al. (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Journal of Clinical Endocrinology and Metabolism, 91, 1578 1581.
19. Mancia, G., De Backer, G., Dominiczak, A. et al. (2007) 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. Journal of Hypertension, 25, 1751 1762.
20. Ebinuma, H., Miyazaki, O., Yago, H. et al. (2006) A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clinica Chimica Acta, 372, 47 53.
21. Pajvani, U.B., Trujillo, M.E., Combs, T.P. et al. (2005) Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nature Medicine, 11, 797 803.
22. Lopez-Bermejo, A., Chico-Julia, B., Fernandez-Balsells, M. et al. (2006) Serum visfatin increases with progressive beta-cell deterioration. Diabetes, 55, 2871 2875.
23. Dogru, T., Sonmez, A., Tasci, I. et al. (2007) Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Research and Clinical Practice, 76, 24 29.
24. Sandeep, S., Velmurugan, K., Deepa, R. et al. (2007) Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism, 56, 565 570.
25. Haider, D.G., Schaller, G., Kapiotis, S. et al. (2006) The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia, 49, 1909 1914.
26. Cobelli, C., Toffolo, G.M., Dalla Man, C. et al. (2007) Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. American Journal of Physiology. Endocrinology and Metabolism, 293, E1 E15.
27. Berndt, J., Kloting, N., Kralisch, S. et al. (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 54, 2911 2916.
28. Haider, D.G., Holzer, G., Schaller, G. et al. (2006) The adipokine visfatin is markedly elevated in obese children. Journal of Pediatric Gastroenterology and Nutrition, 43, 548 549.
29. Kieffer, T.J. Habener, J.F. (2000) The adipoinsular axis: effects of leptin on pancreatic beta-cells. American Journal of Physiology. Endocrinology and Metabolism, 278, E1 E14.
30. Retnakaran, R., Youn, B.S., Liu, Y. et al. (2008) Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study. Clinical Endocrinology (Oxford), 69, 885 893.